RY 167.78 0.209% SHOP 136.85 -0.1168% TD 88.39 0.0566% ENB 64.32 -0.6334% BN 76.45 -0.2089% TRI 256.88 0.8797% CNQ 39.19 -2.1229% CP 103.44 -0.0869% CNR 137.95 -1.4502% BMO 135.26 0.3115% BNS 69.61 0.0% CSU 5054.0098 0.2259% CM 88.72 0.8182% MFC 43.49 -0.1836% ATD 71.21 -0.308% NGT 73.02 2.6427% TRP 69.92 -0.5971% SU 48.43 -2.6337% WCN 274.09 0.3331% L 227.33 1.0266%
Tempus AI, Inc
Tempus AI, Inc. (NASDAQ: TEM) is a technology-driven company focused on advancing diagnostics across various disease areas. It combines data and analytics to support personalized medicine. The company operates through three main product lines: genomics, data, and artificial intelligence (AI) applications. Its genomics segment utilizes advanced laboratory technologies to offer next-generation sequencing, diagnostic testing, PCR, molecular profiling, genotyping, and other forms of anatomic and molecular pathology analysis.
As per our previous US Dailies Report published on ‘TEM’ on March 24, 2025, Kalkine provided an ‘Buy’ stance on the stock at USD 51.35 based on fundamental analysis and the stock price has now moved down by ~11.12% since then.
Noted below are the details of support and resistance levels provided in our previous report:
Xxxxxx Xxxxxx Xxxxxx
Xxxxxx Xxxxxx
Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx .
Xxxxxx Xxxxxx Xxxxxx Xxxxxx & Xxxxxx
Xxxxxx Xxxxxx
Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx .
Xxxxxx
Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx .
Enter your details below and our team will help you to decide if this product is best for you.
The advice given by Kalkine Canada Advisory Services Inc. and provided on this website is general information only and it does not take into account your investment objectives, financial situation and the particular needs of any particular person. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. The website www.kalkine.ca is published by Kalkine Canada Advisory Services Inc. The link to our Terms & Conditions has been provided please go through them. On the date of publishing this report (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.
CA
NZ
UK
US
AU
IND
Please wait processing your request...